Background The impact of first-stage resection on volume regeneration of segments 2 and 3 (2+3) after right portal vein embolization (RPVE) in patients undergoing two-stage right hepatectomy has not been investigated. Method Volume data for segments 2+3 were compared between 44 patients undergoing two-stage hepatectomy and 116 undergoing single-stage hepatectomy after RPVE. Results The degree of hypertrophy (difference between standardized volume of segments 2+3 before and after RPVE) and kinetic growth rate (degree of hypertrophy at initial volume assessment divided by the number of weeks elapsed after RPVE) were significantly lower in patients undergoing two-stage hepatectomy (median 8.6 vs 10.5 % [p=0.01] and 1.7 vs 2.4 % [p<0.01], respectively). Resection volume during first-stage resection was negatively correlated with standardized volume increase from the volume before first-stage resection (R 2 0.546, p<0.01). In patients undergoing two-stage hepatectomy after RPVE with segment 4 embolization, the degree of hypertrophy and kinetic growth rate were similar to those in patients undergoing single-stage hepatectomy (p=0.17 and p=0.08, respectively). Conclusion In patients undergoing two-stage hepatectomy, first-stage resection impairs the dynamics of volume regeneration of segments 2+3 after RPVE. When two-stage extended right hepatectomy is planned, additional embolization of segment 4 provides volume hypertrophy similar to that in patients undergoing single-stage hepatectomy.
Introduction
Liver resection is the mainstay of treatment for colorectal liver metastases (CLM), providing long-term survival and in some cases cure of the disease. However, the majority of patients with CLM present with an unresectable disease at diagnosis. 1, 2 The current issue in the treatment of CLM is how to refine multidisciplinary approaches to expand the proportion of patients who are candidates for liver resection.
Two-stage hepatectomy is a modern strategy for resection of extensive bilateral CLM that cannot be resected by conventional single-stage resection. 1, [3] [4] [5] [6] [7] [8] An interval between first-stage tumor clearance in the future liver remnant (FLR) and staged resection expands technical resectability in patients with insufficient FLR by inducing hypertrophy of FLR. To accelerate the interval hypertrophy, portal vein occlusion technique plays an important role in two-stage major resection. Recent reviews demonstrated that more than 70 % cases of two-stage hepatectomy combine this technique, preferring portal vein embolization (PVE) after first-stage resection, 7 which enables additional embolization of segment 4 when performing two-stage extended right hepatectomy. 4, 7, [9] [10] [11] Increasing evidence has demonstrated the safety and efficacy of PVE in patients undergoing two-stage hepatectomy. 4, 6, 7, 12, 13 However, it remains uncertain how first-stage resection for tumor clearance in the FLR influences the dynamics of volume regeneration of the FLR after PVE. We previously reported that the magnitude and speed of liver growth after PVE are good predictors of postoperative outcomes in patients undergoing liver resection following PVE. 14, 15 The impact of first-stage resection on liver volumetric change in patients undergoing two-stage hepatectomy needs to be clarified to improve not only the technical resectability but also the overall safety of the aggressive surgical approach.
The aim of this study was to determine the impact of firststage resection on the dynamics of volume regeneration of the FLR after right PVE (RPVE) in patients undergoing two-stage right hepatectomy (RH). We compared volumetric data for segments 2 and 3 (S2+3) between patients undergoing twostage RH after RPVE and patients undergoing single-stage RH after RPVE.
Patients and Methods
The Institutional Review Board of The University of Texas, MD Anderson Cancer Center approved this study protocol. The prospectively maintained liver resection database of the Department of Surgical Oncology was queried to identify 208 patients who underwent RPVE prior to liver resection for CLM during the period from September 1999 to August 2012. Of these 208 patients, 47 did not have volumetric data available for S2 +3, either because single-stage RH was planned and the volume of S2+3 was not separately calculated (n=21) or because computed tomography (CT) imaging was not performed after first-stage resection in 26 patients undergoing twostage RH. One patient who underwent complete resection of S2+3 prior to two-stage RH was also excluded. The remaining 160 patients constituted the study cohort. Forty-four patients underwent RPVE after first-stage resection as part of two-stage RH and 116 underwent RPVE prior to planned single-stage RH.
Right Portal Vein Embolization
All patients with a potentially resectable disease underwent liver volumetry based on CT imaging, and standardized total liver volume (sTLV) was estimated according to the method described previously. 16, 17 PVE was considered when standardized FLR was less than 20 % in patients with normal liver or less than 30 % in patients with impaired liver function. All embolizations were performed with the ipsilateral percutaneous transhepatic approach using tris-acryl microspheres. When extended right hepatectomy was planned, RPVE extended to segment 4 branches (RPVE+4) was performed.
Two-Stage Right Hepatectomy
Two-stage RH was planned in patients with advanced bilateral CLM in whom first-stage limited resection could clear the tumors in the left liver before the patient underwent a planned right hepatectomy. In patients undergoing two-stage RH, RPVE was performed after first-stage resection, and then, RH was performed when sufficient volume regeneration was confirmed without tumor progression. To avoid the risk associated with extended chemotherapy, interval chemotherapy was not used routinely. 1 In patients undergoing two-stage RH, baseline CT volumetry was conducted after first-stage resection.
Volumetric Analysis (Fig. 1) 1) Post-RPVE evaluation of hypertrophy All patients underwent three-dimensional CT volumetry 2 to 8 weeks after RPVE to assess the extent of liver hypertrophy. The degree of hypertrophy (DH) of S2+3 was defined as the percentage point difference between the volume of S2+3/ sTLV before and after RPVE. Kinetic growth rate (KGR) of S2+3 was calculated using the following formula: KGR=DH at first post-RPVE volume assessment (%)/time elapsed since RPVE (weeks) at first post-RPVE volume assessment (Fig. 1) . Hypertrophy rate of S2+3 was also calculated using the following formula: Hypertrophy rate=(post-RPVE volume of S2+3−pre-RPVE volume of S2+3)/pre-RPVE volume of S2+3 (%). If hypertrophy at the volume assessment was insufficient to the abovementioned criteria, serial volumetry and assessment of disease progression were performed based on CT imaging.
2) Impact of resection volume during first-stage resection on liver regeneration after RPVE
To assess the impact of resection volume during first-stage resection on liver regeneration after RPVE, the correlation between resection volume of S2+3 during first-stage resection and DH was analyzed. Resection volume during first-stage resection was calculated by the following formula: Resection volume=volume of S2+3 before first-stage resection−volume of S2+3 before RPVE. The tumor volume was excluded from the volume of S2+3 before first-stage resection. The degree of hypertrophy of S2+3 from the status prior to firststage resection (DH 0 ) was defined as the percentage point difference between the volume of S2+3/sTLV before firststage resection and after RPVE (Fig. 1 ).
Statistical Analysis
Background patient characteristics and volumetric data were compared between patients undergoing two-stage RH and single-stage RH. Categorical variables were compared using the chi-squared test. Continuous variables were compared using the Mann-Whitney U test and expressed as median (range). p<0.05 was considered statistically significant.
To identify predictors of DH and KGR, the following clinicopathological variables were evaluated in a univariate proportional hazards models: age (≤65 vs >65 years), sex, body surface area (<2.0 vs ≥2.0 m 2 ), body mass index (≤25 vs >25 kg/m 2 ), American Society of Anesthesiologists score (<3 vs ≥3), the presence of diabetes mellitus, the presence of hepatitis B or C, administration of two-stage RH, administration of RPVE+4, the presence of RPVE complication, duration of pre-RPVE chemotherapy (≤12 vs >12 weeks), administration of cytotoxic drug (oxaliplatin, irinotecan), administration of targeted agents (bevacizumab, cetuximab, or panitumumab), history of previous hepatectomy for CLM, and the presence of background liver damage (fibrosis [F1-4], >30 % steatosis, or moderate to severe sinusoidal injury). All variables associated with p≤0.1 in the univariate analysis were subsequently entered into a Cox multivariate regression model with backward elimination. The Student t test and Pearson correlation coefficient were used to investigate the impact of resection volume during first-stage resection on liver regeneration after RPVE. p<0.05 was considered statistically significant.
Results

Clinicopathologic Characteristics
Clinicopathologic characteristics of the single-stage and two-stage RH groups are summarized in Table 1 . No patients in the two-stage RH group had diabetes mellitus, whereas 12 % of patients in the single-stage RH group did (p=0.01). The presence of background liver damage was not available in 14 patients in the single-stage RH group who did not undergo liver resection. In the two-stage RH group, for first-stage resection, the median number of limited resections performed was 2 (range, 1-5). The median hospital stay was 6 days (range, 3-13 days). One patient developed a postoperative pleural effusion that necessitated thoracocentesis. No other patient had a major complication as defined by the Dindo classification (>grade II) after first-stage resection. 18 Volumetric Data Volumetric data for S2+3 are presented in 2. DH and KGR values for both groups are plotted in Fig. 2 . The interval between RPVE and final CT volumetry assessment was significantly longer in the two-stage RH group than the single-stage RH group (p<0.01). Although the pre-RPVE volumetric data for S2+3 were similar for the two groups, DH and KGR were significantly lower in the two-stage RH group than in the single-stage RH group (p =0.01 and p<0.01, respectively). hepatectomy is planned to achieve favorable growth of S2+3.
Although it is well established that partial hepatectomy induces hypertrophy of the liver, [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] we found that partial hepatectomy of the FLR prior to PVE did not accelerate but rather impaired hypertrophy induced by PVE. This finding can be explained by three separate findings previously reported in literature. First, the effect of liver regeneration after hepatectomy is to revert the volume to the preoperative status, not to surpass the original volume. 19, 21, 23, 24 Second, complete regeneration of the resected liver generally takes 6 months 23, 28 to 1 year 25, 26 after surgery. Finally, a positive correlation has been found between resection volume and hypertrophy of the liver after hepatectomy, and a small resection does not trigger liver hypertrophy. [21] [22] [23] 29, 30 On the basis of these previously reported findings, the reported interval of 3 months between first-stage and second-stage hepatectomy may not be sufficient to allow the liver to fully recover from the previous hepatectomy in terms of volume regeneration, 4, 7 and the small resection volume during first-stage resection, generally less than 10 % of sTLV (Fig. 4) , does not trigger hypertrophy after liver resection nor accelerate the effect of PVE. Further investigation at a molecular level needs to be conducted to clarify the mechanism of impairment of volume regeneration after PVE in patients undergoing two-stage RH because sound hypertrophy after PVE is the key to completing the procedure and lowering morbidity.
Our finding that resection volume during first-stage resection negatively correlated with the degree of hypertrophy estimated from the status before first-stage resection in patients undergoing two-stage RH has a clinical implication. Specifically, when we plan the strategy for two-stage procedures, we anticipate the volume increase induced by RPVE on the basis of the imaging before first-stage resection. If large parenchymal loss is inevitable because of the need to remove centrally located tumors or multiple tumors, we need to estimate less volume increase induced by RPVE. Furthermore, during first-stage resection, a parenchymal-sparing approach needs to be used to maximize the effect of portal vein manipulation.
Additional segment 4 embolization during RPVE offsets the negative impact of first-stage resection, inducing volume regeneration of S2+3 similar to that in patients undergoing single-stage RH. The trophic effect of RPVE+4 on volume regeneration of S2+3 has been clarified previously. 9, 10, 31 The current study went a step further by focusing on patients undergoing two-stage hepatectomy and revealed that the additional embolization halved the negative effect of the resection volume during first-stage resection on DH 0 (Fig. 4a) . In addition, volume increase from the status after first-stage resection can be boosted by RPVE+4 with a positive correlation with resection volume (Fig. 4b) . The boosting effect becomes important when first-stage hepatectomy entails large parenchymal loss to accomplish radical clearance of tumors in the FLR. Although the pure increase from the status before first-stage resection (DH 0 ) diminishes according to resection volume, RPVE+4 compensates for the loss of liver volume by accelerating hypertrophy induced by RPVE. On the basis of these findings, additional embolization of segment 4 needs to be performed when two-stage extended right hepatectomy is planned and when first-stage resection removes large parenchyma in the FLR to achieve favorable growth of S2+3. We previously reported the safety of segment 4 embolization both in single-and two-stage hepatectomy. 9, 12 However, specialized expertise is needed to accurately embolize segment 4 branches while preserving non-targeted portal vein. Technological advances may overcome this problem. We have recommended the use of C-arm CT to help with the acquisition of angiographic and three-dimensional images. 9, 32 Multivariate analysis in patients undergoing RPVE revealed that two-stage hepatectomy and RPVE without embolization of segment 4 were procedure-related risk factors impairing DH and KGR of S2+3 after RPVE. Several authors have reported factors predictive of liver regeneration following PVE, such as pre-PVE FLR volume, 20, 29 receipt of chemotherapy, 33 and functional hepatic reserve. 33, 34 However, their analyses were based on the hypertrophy rate of the FLR (increase of FLR/pre-PVE FLR). In contrast, we investigated predictors including administration of two-stage hepatectomy based on DH (increase of standardized volume of S2+3) and KGR (DH at first assessment/time elapsed since PVE) because these kinetic profiles are able not only to evaluate the trophic effects of PVE but also to predict postoperative morbidity and mortality after major hepatectomy. 14, 15 In the clinical setting, assessment of volume regeneration after PVE is based on the pure increase in the volume of the FLR, not on the rate of the increase. Hence, the prediction of these kinetic profiles would be clinically relevant to optimize the strategy for two-stage RH combined with PVE.
The limitations of this study include its retrospective nature and the small number of patients in the two-stage RH group (n=44). Differences in tumor burden between single-and twostage RH groups, which were not assessed in this study, may have affected volume regeneration after RPVE. In addition, comparison between RPVE and RPVE+4 in the two-stage RH group did not show significant differences in volumetric parameters because of the small number of patients in each group as we previously reported. 12 This study focused on investigating the impact of first-stage resection on volume regeneration after PVE, comparing parameters between patients with and without first-stage resection. Then, subanalysis of the two-stage RH group revealed the effect of RPVE+4, which is one of the key procedures in two-stage RH. Further investigation needs to be conducted to confirm the findings of this study because the effect of RPVE+4 demonstrated in this study can increase the completion rate of two-stage extended right hepatectomy, which provides an excellent prognosis in patients with extensive bilateral CLM.
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Conclusion
In conclusion, first-stage partial hepatectomy had a negative impact on volume regeneration of S2+3 after RPVE in patients undergoing two-stage RH. When two-stage extended right hepatectomy is planned, additional embolization of segment 4 provides volume regeneration similar to that in patients undergoing single-stage hepatectomy.
